Method . | Modality . | Samples . | ACC (%) . |
---|---|---|---|
3D-CNN | MRI + SNP + EHR | 267 (NC)/128 (AD) | 86.00 |
C-GNN | fMRI | 960 (NC)/592 (AD) | 85.80 |
SVM | MRI | 74 (EMCI)/38 (LMCI) | 64.30 |
FSN + PFC | fMRI | 29 (EMCI)/18 (LMCI) | 80.85 |
C-GNN | fMRI | 638 (LMCI)/592 (AD) | 65.20 |
TLA | MRI | 70 (LMCI)/75 (AD) | 76.73 |
FIAD-GAN | fMRI + SNP | 237 (NC)/233 (AD) | 93.62 |
197 (EMCI)/203 (LMCI) | 91.25 | ||
203 (LMCI)/233 (AD) | 91.95 |
Method . | Modality . | Samples . | ACC (%) . |
---|---|---|---|
3D-CNN | MRI + SNP + EHR | 267 (NC)/128 (AD) | 86.00 |
C-GNN | fMRI | 960 (NC)/592 (AD) | 85.80 |
SVM | MRI | 74 (EMCI)/38 (LMCI) | 64.30 |
FSN + PFC | fMRI | 29 (EMCI)/18 (LMCI) | 80.85 |
C-GNN | fMRI | 638 (LMCI)/592 (AD) | 65.20 |
TLA | MRI | 70 (LMCI)/75 (AD) | 76.73 |
FIAD-GAN | fMRI + SNP | 237 (NC)/233 (AD) | 93.62 |
197 (EMCI)/203 (LMCI) | 91.25 | ||
203 (LMCI)/233 (AD) | 91.95 |
Method . | Modality . | Samples . | ACC (%) . |
---|---|---|---|
3D-CNN | MRI + SNP + EHR | 267 (NC)/128 (AD) | 86.00 |
C-GNN | fMRI | 960 (NC)/592 (AD) | 85.80 |
SVM | MRI | 74 (EMCI)/38 (LMCI) | 64.30 |
FSN + PFC | fMRI | 29 (EMCI)/18 (LMCI) | 80.85 |
C-GNN | fMRI | 638 (LMCI)/592 (AD) | 65.20 |
TLA | MRI | 70 (LMCI)/75 (AD) | 76.73 |
FIAD-GAN | fMRI + SNP | 237 (NC)/233 (AD) | 93.62 |
197 (EMCI)/203 (LMCI) | 91.25 | ||
203 (LMCI)/233 (AD) | 91.95 |
Method . | Modality . | Samples . | ACC (%) . |
---|---|---|---|
3D-CNN | MRI + SNP + EHR | 267 (NC)/128 (AD) | 86.00 |
C-GNN | fMRI | 960 (NC)/592 (AD) | 85.80 |
SVM | MRI | 74 (EMCI)/38 (LMCI) | 64.30 |
FSN + PFC | fMRI | 29 (EMCI)/18 (LMCI) | 80.85 |
C-GNN | fMRI | 638 (LMCI)/592 (AD) | 65.20 |
TLA | MRI | 70 (LMCI)/75 (AD) | 76.73 |
FIAD-GAN | fMRI + SNP | 237 (NC)/233 (AD) | 93.62 |
197 (EMCI)/203 (LMCI) | 91.25 | ||
203 (LMCI)/233 (AD) | 91.95 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.